Literature DB >> 8240399

Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells.

P Seth1, H L Fung.   

Abstract

A membrane-bound enzyme responsible for generating nitric oxide (NO) from nitroglycerin (NTG) in vascular smooth muscle cells has been characterized. The enzyme could be solubilized from vascular microsomes by several detergents, the most effective of which was 3-[(3-cholamidopropyl)-dimethylamino]-1-propanesulfonate (CHAPS). A partially purified enzyme preparation was obtained with CHAPS-solubilized vascular microsomes that were processed sequentially through an ion exchange column and a gel filtration column. The activity of this partially purified enzyme showed a dependence on substrate concentration, protein concentration and the duration of incubation. Enzyme activity was enhanced 2.7- to 4.2-fold by several thiols such as cysteine, N-acetylcysteine, reduced glutathione, and dithiothreitol. On the other hand, N-ethylmaleimide, iodoacetic acid, p-chloromercuric benzoic acid and 1-chloro-2,4-dinitrobenzene, reagents known to bind with the free sulfhydryl groups, inactivated the NO-generating activity from NTG. The enzyme activity could be reversibly bound to an organomercurial column. These results suggested the presence of a free thiol group in the enzyme and that this thiol group was required for enzyme activity. The partially purified enzyme was active in the presence of 0.1% sodium dodecyl sulfate (SDS). The enzyme was purified to near homogeneity using several sequential chromatographic steps including DEAE-Sephacel, Biogel A 1.5 m, hydroxylapatite and organomercurial columns, resulting in an increase in enzyme activity of about 94-fold. The subunit of this enzyme, as identified on an SDS-treated electrophoresis gel, had an apparent molecular size of 58 kDa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240399     DOI: 10.1016/0006-2952(93)90115-d

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

Review 3.  After 130 years, the molecular mechanism of action of nitroglycerin is revealed.

Authors:  Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

4.  Identification of the enzymatic mechanism of nitroglycerin bioactivation.

Authors:  Zhiqiang Chen; Jian Zhang; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

Review 5.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

6.  Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cell.

Authors:  Natália Aparecida de Paula; Andressa Megumi Niwa; Diogo Campos Vesenick; Carolina Panis; Rubens Cecchini; Angelo de Fátima; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

Review 7.  Nitric Oxide-Releasing Macromolecular Scaffolds for Antibacterial Applications.

Authors:  Lei Yang; Evan S Feura; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  Adv Healthc Mater       Date:  2018-05-14       Impact factor: 9.933

8.  Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.

Authors:  S C Ijioma; R A Challiss; J P Boyle
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.

Authors:  A Mülsch; A Bara; P Mordvintcev; A Vanin; R Busse
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.

Authors:  M Civelli; M Giossi; P Caruso; R Razzetti; M Bergamaschi; S Bongrani; A Gasco
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.